CKS2 and lung colloid adenocarcinoma: To determine the diagnostic ability of CKS2 to distinguish stages I–III invasive non-mucinous lung adenocarcinoma patients from healthy samples, ROC curves were generated using the TCGA combined with the GTEx dataset (training cohort) and the immunohistochemical scores of 90 samples (validation cohort).